Models/press release/2026-09-21

MindWalk deploys OpenFold3 on AMD GPUs via Vultr for drug discovery

MindWalk announced the deployment of OpenFold3, an AI model for protein structure prediction, on AMD GPUs within the Vultr cloud infrastructure. This collaboration, reported by both 01net and HPCwire, aims to accelerate drug discovery efforts. The deployment leverages AMD inference microservices and Vultr Kubernetes Engine to streamline the process.

2 articles from 2 outlets covered this story. The underlying claim is sourced from a press release.

What do all outlets agree on?

2 outlets covered “MindWalk deploys OpenFold3 on AMD GPUs via Vultr for drug discovery”. All of them report the following:

  • MindWalk deployed OpenFold3
  • Deployment uses AMD GPUs
  • Deployment uses Vultr cloud infrastructure
  • Purpose is drug discovery

Which outlets covered this?

All 2 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.

What related stories are there?

Which companies does this involve?

Get the week in AI in one email

What happened, which outlets reported it, and where their coverage differed. One issue a week.

The first issue hasn’t gone out yet. Subscribe and it’s the one you’ll get.

We’ll send the digest and nothing else. One-click unsubscribe. Privacy.